You are here

Article Text

Article menu

Download PDFPDF

At a glance
Highlights from this issue
Free
  1. Keith Barton1,
  2. Jost B Jonas2,
  3. James Chodosh3, Editors in chief
  1. 1 Moorfields Eye Hospital, London, UK
  2. 2 Department of Ophthalmology, Ruprecht-Karls-University Heidelberg, Seegartenklinik Heidelberg, Mannheim, Germany
  3. 3 Ophthalmology, Massachusetts Eye and Ear Infirmary Howe Laboratory Harvard Medical School, Boston, Massachusetts, USA
  1. Correspondence to Keith Barton, Moorfields Eye Hospital, London E1V 2PD, UK; BJO{at}keithbarton.co.uk

https://doi.org/10.1136/bjophthalmol-2019-315168

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Incidence of exudative age-related macular degeneration and treatment load under the Korean National health insurance system in 2010–15 (see page 1361)

    This population-based cohort study investigated the incidence of exudative age-related macular degeneration and associated use of ranibizumab and aflibercept in South Korea, which is one of the few Asian countries providing national health care insurance.

    Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion (see page 1367)

    Eyes with greater loss of macular capillaries after an initial intravitreal ranibizumab injection were noted to have fewer recurrences of macular oedema in eyes with a prior branch retinal vein occlusion.

    Collateral vessels on optical coherence tomography angiography in eyes with branch retinal vein occlusion (see page 1373)

    Collateral vessel formation was observed in the acute phase in eyes with BRVO and more frequently after major or ischaemic type BRVO's. In addition, the presence of collateral vessels was associated with resolution of macular oedema, though the presence of microaneurysms in the collateral vessels was sometimes positively associated with macular oedema.

    Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients (see page 1380)

    The incidence of prolonged adverse intraocular pressure elevation was significantly lower than reported in previous Western population-based studies. Intravitreal dexamethasone injection may be an effective and safe treatment modality for macular oedema in Asian patients.

    Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of anti-vascular endothelial growth factor agents: a randomised crossover trial (see page 1388)

    In this randomised crossover trial of 58 eyes without glaucoma, the intraocular pressure spike following intravitreal injection of anti-VEGF agents was significantly reduced from a mean of 42mmHg to 34mmHg when topical brimonidine tartrate was pre-administered.

    Success of trabeculectomy surgery in relation to cataract surgery: 5-year outcomes (see page 1395)

    Trabeculectomy success at 5 years was similar, in eyes which had trabeculectomy alone, cataract surgery and then trabeculectomy any time afterwards, and trabeculectomy with cataract surgery performed …

    View Full Text

    Linked Articles